title: Zygomycosis in neutropenic patients with past Aspergillus infection: a role for posaconazole?
authors.forename: L
authors.initials: L
authors.lastname: Ide
authors.forename: I
authors.initials: I
authors.lastname: Buysschaert
authors.forename: H
authors.initials: H
authors.lastname: Demuynck
authors.forename: R
authors.initials: R
authors.lastname: De Man
authors.forename: A
authors.initials: A
authors.lastname: Verlinde
authors.forename: E
authors.initials: E
authors.lastname: De Laere
authors.forename: I
authors.initials: I
authors.lastname: Surmont
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use*; D001228:Aspergillosis / Q000150:complications*; D006801:Humans; D009503:Neutropenia / Q000150:complications*; D014230:Triazoles / Q000627:therapeutic use*; D020096:Zygomycosis / Q000188:drug therapy*
chemical_list: D000935:Antifungal Agents; D014230:Triazoles; C101425:posaconazole